ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers.

Julia Rotow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.